about
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.IDH mutation impairs histone demethylation and results in a block to cell differentiationAssessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaDifferential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitorsIntegration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluidPhase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
P50
Q27852141-C62A34DB-60FB-477D-BD5D-3A4FAEAA8C01Q29305058-30D40904-8828-4907-9CD4-91CFB13BC297Q30014823-75B582F5-82C6-4186-A0F4-7A0C0E791897Q35967385-60665606-C0F7-40B2-9F50-B9A5513906E1Q36493858-4FE50E1E-EDE0-4AF6-9FA6-34AB13BE6D1FQ36494583-EE01F965-6F85-468B-8318-71D042B53882Q38723290-C7930B33-6C24-457E-A223-6A6C0DCE66F4Q47111538-36F45198-E4B0-4ACA-ACD2-8B66BDD6B21CQ62745703-4C5243AC-A13E-4024-97F0-F54586B11A6EQ64230024-4CB5A2C7-496A-4834-9AF2-02D5EA92A472
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ingo K Mellinghoff
@en
Ingo K Mellinghoff
@nl
type
label
Ingo K Mellinghoff
@en
Ingo K Mellinghoff
@nl
prefLabel
Ingo K Mellinghoff
@en
Ingo K Mellinghoff
@nl
P31
P496
0000-0002-4347-8149